Cara Therapeutics
CARA
$0.70
Share price
4.23%
Change (1 day)
-82.19%
Change (1 year)
Categories
Cara Therapeutics (CARA) Fails to deliver data
Key failure to deliver metrics for Cara Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $0.04 M
- Last year FTD volume: $2.53 M
Failures to deliver for Cara Therapeutics (CARA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Cara Therapeutics (CARA) - since 2014
Volume in USD (price x number of shares), data since 2014Cara Therapeutics (CARA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.04 M | -98.87% |
| 2023 | $3.66 M | 94.04% |
| 2022 | $1.88 M | -93.67% |
| 2021 | $29.84 M | 385.25% |
| 2020 | $6.14 M | -81.07% |
| 2019 | $32.47 M | 0.96% |
| 2018 | $32.16 M | -82.42% |
| 2017 | $0.18 B | 1899.54% |
| 2016 | $9.15 M | 217.32% |
| 2015 | $2.88 M | -61.24% |
| 2014 | $7.44 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Trevena TRVN | $0.02 M | $1.41 M | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | N/A | $0.02 M | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $0.05 M | $0.85 M | 🇺🇸 USA |